Anafranil (Clomipramine) vs Dicyclomine: Key Differences
These are completely different medications used for entirely different conditions: Anafranil (clomipramine) is a tricyclic antidepressant primarily indicated for obsessive-compulsive disorder and depression, while dicyclomine is an antispasmodic used for irritable bowel syndrome.
Indications
Anafranil (Clomipramine):
- Primary indication: Obsessive-compulsive disorder (OCD) 1
- Also used for treatment-resistant depression 2
- Effective for panic disorder 2
Dicyclomine:
- Indicated specifically for functional bowel/irritable bowel syndrome (IBS) 3
- Used to reduce abdominal pain and smooth muscle spasm 4
Mechanism of Action
Anafranil (Clomipramine):
- Non-selective serotonin reuptake inhibitor (SRI) 1
- Blocks reuptake of serotonin as primary action 5
- Its metabolite (desmethylclomipramine) is a potent norepinephrine reuptake inhibitor 5
- Has significant anticholinergic properties 2
Dicyclomine:
- Anticholinergic/antimuscarinic agent 6
- Reduces smooth muscle contraction in the gastrointestinal tract 4
- May reduce visceral hypersensitivity 4
Dosing Regimens
Anafranil (Clomipramine):
- For OCD: Response typically requires doses >75 mg/day 5
- Maximum recommended daily dose: 250 mg 5
- Time to steady-state: approximately 3 weeks due to long half-life (24h for parent drug, 96h for active metabolite) 7
- Treatment duration: 8-12 weeks needed to determine efficacy 1
- Maintenance: minimum 12-24 months after achieving remission 1
Dicyclomine:
- Dosing varies by formulation and patient response 4
- Used as needed for symptom control in IBS 4
- Shorter duration of action compared to clomipramine
Contraindications
Anafranil (Clomipramine) - Absolute Contraindications 8:
- Hypersensitivity to clomipramine or other tricyclic antidepressants
- Concurrent use with MAOIs or within 14 days of MAOI discontinuation (serotonin syndrome risk)
- Use with linezolid or IV methylene blue
- Acute recovery period after myocardial infarction
Dicyclomine - Contraindications 3:
- Infants <6 months of age
- Nursing mothers
- Unstable cardiovascular status in acute hemorrhage
- Myasthenia gravis
- Glaucoma
- Obstructive uropathy
- Obstructive gastrointestinal disease
- Severe ulcerative colitis
- Reflux esophagitis
Adverse Effects Profile
Anafranil (Clomipramine):
- Predominantly anticholinergic effects (dry mouth, dizziness, blurred vision) 2
- Urinary retention is a significant concern 9
- Sexual dysfunction 1
- Seizure risk: 0.48% at ≤250 mg/day, 2.1% at ≥300 mg/day 2
- Cardiovascular effects 5
- Gastrointestinal symptoms 1
Dicyclomine:
- Anticholinergic effects (dry mouth, dizziness, blurred vision) 4
- Generally mild to moderate adverse effects 4
- No serious adverse events reported in trials 4
- May worsen constipation due to anticholinergic effects 4
Clinical Considerations
Therapeutic monitoring for clomipramine: Blood concentrations <150 mcg/L associated with nonresponse; >450 mcg/L rarely improve efficacy. Narrow therapeutic range makes monitoring valuable 7.
Drug interactions: Clomipramine shows significant interactions with neuroleptics (especially phenothiazines), and its metabolism is affected by smoking and alcohol 7. Recent evidence shows competitive inhibition of other drug metabolism via CYP2D6 10.
Efficacy comparison within class: For OCD, clomipramine may be more efficacious than SSRIs in meta-analyses, though head-to-head trials show equivalent efficacy. SSRIs are preferred first-line due to superior safety and tolerability profile 1.
For IBS: Dicyclomine shows improvement in global IBS symptoms (RR 0.67) and abdominal pain (RR 0.74) compared to placebo, though evidence certainty is low to very low 4.